Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2018; 07(01): 64-65
DOI: 10.4103/sajc.sajc_17_18
Letter to the Editor

Neoadjuvant chemotherapy in locally advanced invasive lobular carcinoma: A limited institutional experience

Ajay Gogia
Department of Medical Oncology, All Institute of Medical Sciences, New Delhi
,
Vinod Raina
Department of Medical Oncology, FMRI, Gurgaon, Haryana
,
S. V. S. Deo
Department of Surgical Oncology, All Institute of Medical Sciences, New Delhi
,
N. K. Shukla
Department of Surgical Oncology, All Institute of Medical Sciences, New Delhi
,
Sandeep Mathur
Department of Pathology, All Institute of Medical Sciences, New Delhi
,
D. N. Sharma
Department of Radiation, All Institute of Medical Sciences, New Delhi
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
22 December 2020

© 2018. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Barroso-Sousa R, Metzger-Filho O. Differences between invasive lobular and invasive ductal carcinoma of the breast: Results and therapeutic implications. Ther Adv Med Oncol 2016;8:261-6.
  • 2 Gogia A, Raina V, Deo SV, Shukla NK, Mohanti BK, Sharma DN, et al. Taxane and anthracycline based neoadjuvant chemotherapy for locally advanced breast cancer: Institutional experience. Asian Pac J Cancer Prev 2014;15:1989-92.
  • 3 Tsung K, Grobmyer SR, Tu C, Abraham J, Budd GT, Valente SA, et al. Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated? Am J Surg 2017. pii: S0002-9610 (17) 30998-4.
  • 4 Karen Tsung B, Stephen R, Grobmyer A, Chao Tu A, Jame Abraham C, Thomas G, et al. Stephanie pathologic predictors of treatment response to neo-adjuvant chemotherapy for invasive lobular breast carcinoma. Breast J 2017;23:607-9.
  • 5 Truin W, Vugts G, Roumen RM, Maaskant-Braat AJ, Nieuwenhuijzen GA, van der Heiden-van der Loo M, et al. Differences in response and surgical management with neoadjuvant chemotherapy in invasive lobular versus ductal breast cancer. Ann Surg Oncol 2016;23:51-7.